Medibank share price resilient as class action law suit hits

The Medibank share price has managed a positive move this morning despite news on legal action regarding the October data breach.

| More on:
A boy stands in still ankle-deep water brandishing a bow and arrow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Medibank share price has moved back into positive territory in morning trade
  • The ASX 200 health insurer is facing a class action lawsuit in relation to October's massive data breach
  • Law firm Maurice Blackburn has lodged a representative complaint with the Office of the Australian Information Commission

The Medibank Private Ltd (ASX: MPL) share price is edging higher in morning trade, up 0.8% after opening 0.2% lower.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock, Australia's largest health insurer, closed yesterday trading for $2.97. Medibank shares are currently trading for $3 apiece.

While that's no huge lift, the Medibank share price has managed a positive move this morning. That's despite what looks to be the commencement of a class action lawsuit in regard to the massive 12 October data breach.

As a quick recap, in October Russian-linked cybercriminals accessed the names, dates of birth, addresses, phone numbers and email addresses of 9.7 million current and former Medibank customers. They also hacked into the health claims data for some 480,000 customers.

The Medibank share price fell more than 20% over the following weeks in the wake of the cyberattack. The health insurer did not pay the ransom demands, and much of the stolen data was published on the dark web.

This morning the company reported that class action lawyers from Maurice Blackburn have lodged a representative complaint with the Office of the Australian Information Commission (OAIC).

Medibank said that the OAIC has not yet been in contact about the complaint.

"The complaint includes allegations that Medibank has breached the Australian Privacy Principles and seeks compensation for individuals whose personal information was exposed as a consequence of the cybercrime," the health insurer stated.

Medibank said it will continue to support its customers with the impact of the cybercrime through its previously announced Cyber Response Support Program. That program includes "mental health and wellbeing support, identity protection and financial hardship measures".

The company also reiterated that it will continue to cooperate with the OAIC in this ongoing investigation.

Medibank share price snapshot

The Medibank share price remains down 15% since October's massive data breach was revealed. As you can see in the chart below, shares are now down 13% year to date.

Created with Highcharts 11.4.3Medibank Private Ltd PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male investor holds a microscope to his eye to represent scrutiny of Wesfarmers share price
Healthcare Shares

Mesoblast shares: Bull vs. bear

Two experts have presented their case for buying and selling the ASX biotech stock.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Should I buy Sigma Healthcare shares for the Chemist Warehouse exposure?

Is this ASX stock a healthy buying opportunity?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Should I buy CSL shares in December?

After a big fall, is this now the time to jump on CSL shares?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Earnings Results

Fisher & Paykel shares surge 8% on half-year results

The market's response was in appreciation of strong results and upgraded guidance.

Read more »

Biotechnology spelt out on green blocks.
Healthcare Shares

Are CSL shares a buy amid the company's $500 million cost-cutting plans?

A leading investment expert delivers his verdict on the outlook for CSL’s beaten-down shares.

Read more »

These three ASX mining shares rocketed by more than 20% today
Healthcare Shares

Guess which $7 billion ASX 200 healthcare share is leaping 14% today

Investors are piling into this ASX 200 healthcare stock on Tuesday. But why?

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

Mesoblast shares push higher on strong sales update

Sales are growing for this biotech. Let's see what it reported today.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This Aussie fertility company has rejected a takeover bid from private equity

Monash IVF has rejected a takeover offer from private equity, saying the bid significantly undervalues the IVF company.

Read more »